Wells Fargo
LKFT

Wells Fargo’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Wells Fargo’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36K Buy
+1,200
New +$39.7K ﹤0.01% 5562
2024
Q2 		– Sell
-432
Closed -$13.9K – 7111
2024
Q1 		$13.9K Buy
+432
New +$16.1K ﹤0.01% 5664
2023
Q4 		– Sell
-192
Closed -$6.63K – 7645
2023
Q3 		$6.63K Sell
192
-10
-5% -$389 ﹤0.01% 5904
2023
Q2 		$8.21K Buy
+202
New +$8.24K ﹤0.01% 5955
2023
Q1 		– Sell
-346
Closed -$15.4K – 7714
2022
Q4 		$15.4K Sell
346
-8,818
-96% -$371K ﹤0.01% 5372
2022
Q3 		$391K Sell
9,164
-346
-4% -$17.7K ﹤0.01% 3846
2022
Q2 		$531K Buy
9,510
+554
+6% +$32.8K ﹤0.01% 3706
2022
Q1 		$556K Buy
8,956
+8,821
+6,534% +$540K ﹤0.01% 4332
2021
Q4 		$8K Sell
135
-219
-62% -$11.4K ﹤0.01% 6616
2021
Q3 		$19K Buy
354
+305
+622% +$18.1K ﹤0.01% 5995
2021
Q2 		$3K Sell
49
-63,565
-100% -$4.85M ﹤0.01% 6458
2021
Q1 		$4.9M Buy
63,614
+6,596
+12% +$608K ﹤0.01% 2876
2020
Q4 		$5.64M Buy
57,018
+8,287
+17% +$1.01M ﹤0.01% 2633
2020
Q3 		$6.92M Buy
48,731
+3,764
+8% +$628K ﹤0.01% 2205
2020
Q2 		$8.87M Buy
44,967
+1,695
+4% +$351K ﹤0.01% 1961
2020
Q1 		$8.48M Sell
43,272
-9,734
-18% -$2.09M ﹤0.01% 1801
2019
Q4 		$11M Sell
53,006
-139
-0.3% -$25.7K ﹤0.01% 1898
2019
Q3 		$8.11M Buy
53,145
+50,350
+1,801% +$8.25M ﹤0.01% 2114
2019
Q2 		$360K Buy
2,795
+1,117
+67% +$133K ﹤0.01% 4609
2019
Q1 		$197K Buy
1,678
+669
+66% +$67.4K ﹤0.01% 4834
2018
Q4 		$93K Sell
1,009
-112
-10% -$11.4K ﹤0.01% 5320
2018
Q3 		$126K Buy
1,121
+13
+1% +$1.37K ﹤0.01% 5246
2018
Q2 		$102K Buy
1,108
+256
+30% +$24.8K ﹤0.01% 5365
2018
Q1 		$85K Buy
852
+190
+29% +$20.5K ﹤0.01% 5374
2017
Q4 		$62K Sell
662
-72
-10% -$6.81K ﹤0.01% 5481
2017
Q3 		$75K Buy
734
+509
+226% +$44.5K ﹤0.01% 5335
2017
Q2 		$17K Buy
225
+150
+200% +$12.6K ﹤0.01% 5660
2017
Q1 		$6K Buy
+75
New +$5.4K ﹤0.01% 5986
2016
Q1 		– Sell
-6
Closed – – 6283
2015
Q4 		$0 Buy
+6
New +$307 ﹤0.01% 6295
2015
Q3 		– Sell
-950
Closed -$49K – 6289
2015
Q2 		$49K Buy
+950
New +$50.4K ﹤0.01% 5329

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo's LKFT Position: Q1 2026 in Review

Wells Fargo opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 1,200 shares worth $36K. The stake represents ﹤0.01% of the portfolio and ranks #5562 among its holdings. This is a return to the name: Wells Fargo previously reported a position in LKFT as recently as Q1 2024.

Wells Fargo first reported a position in LKFT in Q2 2015 and has held it in 30 quarters since. The position peaked at $11M in Q4 2019. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Wells Fargo held 1,200 shares of Lakefront Biotherapeutics American Depositary Shares worth $36K as of Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Wells Fargo position in Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5562 holding.
  • Wells Fargo first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 30 quarters since.
  • Wells Fargo's Lakefront Biotherapeutics American Depositary Shares position peaked at $11M in Q4 2019.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.